Fadi Jebbawi

Head Immunoassays and Biomarker

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fadi Jebbawi is the Head of Immunoassays and Biomarker at Evax, located in Switzerland. His research focuses on immunology, particularly in the contexts of allergic responses and eosinophil biology, as evidenced by his recent publications on interleukin 5, allergen immunotherapy, and immune responses in both equine models and murine studies. Professor Jebbawi’s work contributes to advancing our understanding of allergen-specific immunotherapy and its implications for various immune-related conditions.

Articles (9)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fadi Jebbawi

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Anti‐IL‐5 Vaccination Dampens Allergen‐Specific IgE Levels and Modulates IL‐4 and IL‐5 Th2 Cytokines in Skin Allergy of Mice and Horses

Eosinophils Play a Surprising Leading Role in Recurrent Urticaria in Horses

Phenotypic Shift of an Inflammatory Eosinophil Subset into a Steady-State Resident Phenotype after 2 Years of Vaccination against IL-5 in Equine Insect Bite Hypersensitivity

Interleukin 5‐dependent inflammatory eosinophil subtype involved in allergic insect bite hypersensitivity of horses

Allergen immunotherapy: progress and future outlook

Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection

Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice

Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis.

Loss of Claudin-3 Impairs Hepatic Metabolism, Biliary Barrier Function, and Cell Proliferation in the Murine Liver.

Collaborators (5)

Guido Beldi

Pål Johansen

Fabia Canonica

Angelika Schoster

Antonia Fettelschoss‐Gabriel

Make your next move.